Lataa...
Increased Protection against Pneumococcal Disease by Mucosal Administration of Conjugate Vaccine plus Interleukin-12
Streptococcus pneumoniae is a common cause of respiratory tract infections, its main entry route being the nasal mucosa. The recent development of pneumococcal polysaccharide conjugate vaccines has led to a dramatic improvement in protection against invasive disease in infants and children, but thes...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology
2003
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC166054/ https://ncbi.nlm.nih.gov/pubmed/12874361 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.71.8.4780-4788.2003 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|